Literature DB >> 29404905

Sir Jeffrey Hudson, the midget of the Queen Henrietta Marie.

F Trimarchi1, F De Luca2.   

Abstract

Mesh:

Year:  2018        PMID: 29404905     DOI: 10.1007/s40618-018-0844-x

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  4 in total

1.  Congenital adenohypophysis aplasia: clinical features and analysis of the transcriptional factors for embryonic pituitary development.

Authors:  T Arrigo; M Wasniewska; F De Luca; M Valenzise; F Lombardo; D Vivenza; T Vaccaro; E Coradi; A Biason-Lauber
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

Review 2.  Hypopituitarism in the elderly: a narrative review on clinical management of hypothalamic-pituitary-gonadal, hypothalamic-pituitary-thyroid and hypothalamic-pituitary-adrenal axes dysfunction.

Authors:  L Curtò; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2016-05-21       Impact factor: 4.256

3.  Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study.

Authors:  D Ferone; E Profka; V Gasco; M R Ambrosio; A Colao; C Di Somma; E Puxeddu; G Arnaldi; C Pagano; E Zecchi; A Pietropoli; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  2017-02-04       Impact factor: 4.256

4.  Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.

Authors:  M Cappa; L Iughetti; S Loche; M Maghnie; A Vottero
Journal:  J Endocrinol Invest       Date:  2015-12-28       Impact factor: 4.256

  4 in total
  2 in total

1.  Joseph Boruwlaski: the last court dwarf of the History.

Authors:  F Trimarchi
Journal:  J Endocrinol Invest       Date:  2018-03-20       Impact factor: 4.256

2.  Daniel Lambert, a protagonist of real life with monstrous obesity in eighteenth century in England.

Authors:  F Trimarchi
Journal:  J Endocrinol Invest       Date:  2018-03-08       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.